BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析

◆英語タイトル:BiondVax Pharmaceuticals Ltd (BVXV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140349FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BiondVax Pharmaceuticals Ltd (BiondVax Pharmaceuticals) is a biopharmaceutical company that develops universal flu vaccine. The company provides lead product M-001 is a synthetic peptide-based protein that offers protection against human influenza virus strains including seasonal influenza strains; and pandemic influenza strains such as swine flu and avian flu. Its vaccine helps to provide multi-strain, multi season and long-term protection against various flu viruses. BiondVax Pharmaceuticals uses synthetic peptides in vaccines which offers practical advantages such as relative ease of production, chemical stability, and an avoidance of any infectious or oncogenic potential hazard. The company operates in Israel. BiondVax is headquartered in Ness Ziona, Israel.

BiondVax Pharmaceuticals Ltd Key Recent Developments

Jan 28,2021: BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares
Jan 28,2021: BiondVax Announces Third Quarter 2020 Financial Results & Business Update
Jan 21,2021: BiondVax announces appointment of Amir Reichman as new CEO
Aug 20,2020: BiondVax announces second quarter 2020 financial results

This comprehensive SWOT profile of BiondVax Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BiondVax Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BiondVax Pharmaceuticals Ltd – Key Information
BiondVax Pharmaceuticals Ltd – Overview
BiondVax Pharmaceuticals Ltd – Key Employees
BiondVax Pharmaceuticals Ltd – Key Employee Biographies
BiondVax Pharmaceuticals Ltd – Key Operational Heads
BiondVax Pharmaceuticals Ltd – Major Products and Services
BiondVax Pharmaceuticals Ltd – History
BiondVax Pharmaceuticals Ltd – Company Statement
BiondVax Pharmaceuticals Ltd – Locations And Subsidiaries
BiondVax Pharmaceuticals Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BiondVax Pharmaceuticals Ltd – Business Description
BiondVax Pharmaceuticals Ltd – Corporate Strategy
BiondVax Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
BiondVax Pharmaceuticals Ltd – Strengths
BiondVax Pharmaceuticals Ltd – Weaknesses
BiondVax Pharmaceuticals Ltd – Opportunities
BiondVax Pharmaceuticals Ltd – Threats
BiondVax Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

BiondVax Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BiondVax Pharmaceuticals Ltd, Key Information
BiondVax Pharmaceuticals Ltd, Key Ratios
BiondVax Pharmaceuticals Ltd, Share Data
BiondVax Pharmaceuticals Ltd, Major Products and Services
BiondVax Pharmaceuticals Ltd, History
BiondVax Pharmaceuticals Ltd, Key Employees
BiondVax Pharmaceuticals Ltd, Key Employee Biographies
BiondVax Pharmaceuticals Ltd, Key Operational Heads
BiondVax Pharmaceuticals Ltd, Other Locations
BiondVax Pharmaceuticals Ltd, Subsidiaries
BiondVax Pharmaceuticals Ltd, Key Competitors
BiondVax Pharmaceuticals Ltd, SWOT Analysis
BiondVax Pharmaceuticals Ltd, Ratios based on current share price
BiondVax Pharmaceuticals Ltd, Annual Ratios
BiondVax Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NaturalNano Inc (NNAN):企業の財務・戦略的SWOT分析
    Summary NaturalNano Inc (NaturalNano) is a nanomaterial company that develops and offers proprietary technologies and processes to provide nanotubes. The company’s products include PleximerTM, a turnkey HNT polymer concentrate available in pellet form that can be added directly into a polymer extrud …
  • Petroleo Brasileiro SA (PETR4)-石油・ガス分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Sinolink Worldwide Holdings Ltd:企業の戦略・SWOT・財務情報
    Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hareon Solar Technology Co Ltd (600401):電力:M&Aディール及び事業提携情報
    Summary Hareon Solar Technology Co Ltd (Hareon Solar) is a renewable energy company that manufactures and markets solar energy products. The company offers silicon cells and solar modules. Its products portfolio includes mono crystalline silicon solar cells, poly crystalline silicon solar cells, pol …
  • Thai Vegetable Oil Public Company Limited:企業の戦略・SWOT・財務情報
    Thai Vegetable Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Vegetable Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Intarcia Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that discovers, develops and commercializes drug therapies and reduces effects for chronic diseases. The company’s product candidate include ITCA 650 is in Phase III clinical trial. Its ITCA 650 i …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Composites Horizons, Inc.:企業の戦略・SWOT・財務情報
    Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report Summary Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Absorption Systems LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Absorption Systems LLC (Absorption Systems), formerly Absorption Systems LP is a pre-clinical contract research organization that develops and implements research tools. The organization offers preclinical testing of biologics, drugs, and medical devices. It also develops and implements rese …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務情報
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • C.H. Bailey PLC:企業の戦略・SWOT・財務分析
    C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report Summary C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Innovus Pharmaceuticals Inc (INNV)-製薬・医療分野:企業M&A・提携分析
    Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals), formerly North Horizon Inc is a pharmaceutical company that commercialize, license and develops over-the-counter and consumer healthcare products. The company’s product portfolio comprises BTH testosterone booster; Zestra for female arou …
  • Deluxe Corporation:企業の戦略・SWOT・財務分析
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Acorn Energy, Inc. (ACFN)-エネルギー分野:企業M&A・提携分析
    Summary Acorn Energy, Inc. (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and com …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆